91 results
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
13 May 24
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
8:18am
, combined with a favorable tolerability and safety profile, builds confidence in our planned focal onset seizure studies for PRAX-628, with the first … response.
In the 45 mg cohort (n=3), 100% of patients achieved a complete response.
Safety was consistent with the prior dose escalation study
8-K
EX-1.1
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Other Events
4:30pm
relating to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment which
424B5
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Prospectus supplement for primary offering
4:29pm
of generalized
S-1
PPR events at any assessment period versus baseline. Safety results were consistent with our prior Phase 1 dose escalation study
424B5
q3zm1o nau94rc
27 Mar 24
Prospectus supplement for primary offering
4:49pm
8-K
zqw8ja 085oul4y0
26 Mar 24
Other Events
7:01am
S-3
EX-1.2
9018foq6z4ikpw
5 Mar 24
Shelf registration
9:08am
8-K
EX-99.2
jhf8ikxgi lpy
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
8-K
EX-99.1
6cc5b e1e3sf7q
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
8-K
EX-1.1
45zz4tmwfko g8
12 Jan 24
Other Events
5:23pm
8-K
EX-1.1
y4mom55up d4
7 Dec 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-99.1
o5cuc82l1x7
7 Nov 23
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results
7:35am
8-K
w1u2wom bs
2 Oct 23
Other Events
1:27pm
8-K
hodbb14
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
8-K
EX-99.1
fd6q7il5a098p2ee
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
8-K
EX-99.2
otby9jjg 4j
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am